Back to search
FDAFDA · Food and drugs·Recall number D-0974-2016

CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01

Published June 15, 2016 · Recall initiated: June 1, 2016

Summary

FDA records drug Class III recall D-0974-2016, published June 15, 2016 and initiated June 1, 2016. Recalling firm: Aidarex Pharmaceuticals LLC; Status: Terminated; Reported quantity: 10; Lot: Lot#: 47312-1, Exp 01/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

What to do

Voluntary: Firm initiated · FAX

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Aidarex Pharmaceuticals LLC
Distributor
IN, GA
Lot
Lot#: 47312-1, Exp 01/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CEFTRIAXONE for Injection USP, 250mg/vial, Rx only, MFG: LUPIN LIMITED INDIA, Packaged by Aidarex Pharmaceuticals, NDC 53217-0117-01 recalled?

Yes. FDA published recall D-0974-2016 on June 15, 2016. Reported hazard: CGMP Deviations: Out of specification (OOS) intermediate in the subsequent processes to manufacture the final API.

What should I do if I have this product?

Voluntary: Firm initiated · FAX